Summary: DAV (Disabled American Veterans) reports on the promising results from clinical trials of MDMA-assisted psychotherapy for the treatment of PTSD, stating, “the research has been so promising that the U.S. Food and Drug Administration has granted the drug ‘breakthrough’ status.” MAPS Public Benefit Corporation (MAPS PBC) Acting Medical Director Michael Mithoefer, M.D., explains, “It can be very painful to process trauma, whether you have MDMA or not.” MDMA in conjunction with psychotherapy “tends to make processing more possible,” says Dr. Mithoefer.
Originally appearing here.